Oric Pharmaceuticals (ORIC)
(Delayed Data from NSDQ)
$10.48 USD
-0.34 (-3.14%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $10.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Oric Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ORIC 10.48 -0.34(-3.14%)
Will ORIC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ORIC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ORIC
Oric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy?
Oric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock: Should You Buy?
ORIC: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to Buy
Does Oric Pharmaceuticals (ORIC) Have the Potential to Rally 104.99% as Wall Street Analysts Expect?
What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?
Other News for ORIC
Is ORIC poised for gains? 20 Day Moving Average Support shows up after climbing 2.46%
Oric Pharmaceuticals management to meet virtually with Cantor Fitzgerald
ORIC's price falls by 4.0% on September 19, though its technical setup remains stable.
The technical outlook for ORIC is unchanged after it rises 4.56% on September 18
50 Day Moving Average Support appears for ORIC after 3.49% move